Total Funding
42
Total FundingSeed raised
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
A Pharmaceuticals Company.
- Stelios Tzannis: President & CEOPast Role: Buck Institute, EIR
Brian Kennedy: Co-FounderPast Role: Buck Institute, Professor
About the Company
Delos Pharmaceuticals, Inc. discovers and develops novel polyketide-based therapies to treat chronic disease. The company focuses on novel biological mechanisms that can be used to treat aging-related disease by addressing the basis for disease initiation and progression, such as oxidative, cellular, and environmental stress. Delos Pharmaceuticals,
Inc. was incorporated in 2012 and is based in Novato, California.
